antibody-drug conjugate - Latest Newshttp://news.prlog.org/tag/antibody-drug-conjugate/antibody-drug conjugate - Latest News (Press Releases) - Read news before it's newsen-us3600 FDA Approves Genentech’s Kadcyla, the 1st ADC for Treating HER2-Positivehttp://www.prlog.org/12099694-fda-approves-genentechs-kadcyla-the-1st-adc-for-treating-her2-positive.htmlGenentech have recently announced FDA approval for for the treatment of people with HER2-positive metastatic breast cancer (mBC). Immune Responses in Tumor Microenvironment Workshop (Jan 30, 2013 in San Diego)http://www.prlog.org/12027908-immune-responses-in-tumor-microenvironment-workshop-jan-30-2013-in-san-diego.htmlGTC is proud to present the Immune Responses in Tumor Microenvironment Workshop on Jan 30, 2013 in San Diego, CA. Ronald Swanson to Speak at ImmunoTherapeutics & ImmunoMonitoring Jan 31–Feb 1, 2013http://www.prlog.org/12027904-ronald-swanson-to-speak-at-immunotherapeutics-immunomonitoring-jan-31feb-1-2013.htmlRonald Swanson, Senior Director, Janssen R&D Will Give a Featured Presentation at the 5th ImmunoTherapeutics & ImmunoMonitoring Conference (Jan 31 – Feb 1, 2013 in San Diego, CA) Insight Pharma Affiliated Reports Collection Announces Competitor Analysis: Antibody-Drug Conjugateshttp://www.prlog.org/11851563-insight-pharma-affiliated-reports-collection-announces-competitor-analysis-antibody-drug-conjugates.htmlThis report includes a compilation of current active projects in research and development of antibody-drug conjugates and other immunoconjugates in oncology.